Institutional Ownership Vera Therapeutics, Inc. (VERA)
This table provides information about the institutional ownership of Vera Therapeutics, Inc. (VERA). We have compiled data on the 196 institutions that hold shares in the stock, with a total of 63.9 Million shares, which have been reported (via 13F filing form) to have a value of $1.36 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Avoro Capital Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
5,701,900
shares
|
$121 Million
2.22% of portfolio
|
Q1 2025
Added 1.64%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
4,754,832
shares
|
$101 Million
0.01% of portfolio
|
Q1 2025
Added 8.63%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,337,672
shares
|
$70.9 Million
0.0% of portfolio
|
Q2 2024
Added 0.56%
|
|
Abingworth LLP
London, X0 |
Feb 10, 2023 Q4 2022 |
2,960,231
shares
|
$62.8 Million
19.0% of portfolio
|
Q2 2021
New holding
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
2,918,423
shares
|
$62 Million
0.0% of portfolio
|
Q1 2025
Reduced 1.06%
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
May 15, 2025 Q1 2025 |
2,793,987
shares
|
$59.3 Million
4.94% of portfolio
|
Q4 2023
Added 24.09%
|
|
Commodore Capital LP
New York, NY |
May 15, 2025 Q1 2025 |
2,561,782
shares
|
$54.4 Million
6.03% of portfolio
|
Q1 2025
Added 30.8%
|
|
Vestal Point Capital, LP
New York, NY |
May 15, 2025 Q1 2025 |
2,500,000
shares
|
$53.1 Million
4.29% of portfolio
|
Q1 2025
Added 132.56%
|
|
Kynam Capital Management, LP
Princeton, NJ |
May 15, 2025 Q1 2025 |
2,400,000
shares
|
$51 Million
4.86% of portfolio
|
Q1 2025
Added 64.62%
|
|
Holocene Advisors, LP
New York, NY |
May 15, 2025 Q1 2025 |
2,199,292
shares
|
$46.7 Million
0.17% of portfolio
|
Q1 2025
Added 17.24%
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
2,083,048
shares
|
$44.2 Million
0.0% of portfolio
|
Q1 2025
Added 2.8%
|
|
Eversept Partners, LP
New York, NY |
May 15, 2025 Q1 2025 |
1,898,804
shares
|
$40.3 Million
5.04% of portfolio
|
Q1 2025
Added 18.67%
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
May 14, 2025 Q1 2025 |
1,675,367
shares
|
$35.6 Million
0.03% of portfolio
|
Q1 2025
Added 18.39%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
1,202,809
shares
|
$25.5 Million
0.0% of portfolio
|
Q1 2025
Added 4.29%
|
|
First Light Asset Management, LLC
Edina, MN |
May 15, 2025 Q1 2025 |
1,175,879
shares
|
$25 Million
3.62% of portfolio
|
Q1 2025
Reduced 6.77%
|
|
Integral Health Asset Management, LLC
|
May 15, 2025 Q1 2025 |
1,150,000
shares
|
$24.4 Million
3.21% of portfolio
|
Q4 2024
Added 130.0%
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
May 15, 2025 Q1 2025 |
1,050,000
shares
|
$22.3 Million
0.64% of portfolio
|
Q1 2025
New holding
|
|
Woodline Partners LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
1,000,849
shares
|
$21.2 Million
0.17% of portfolio
|
Q1 2025
Reduced 16.77%
|
|
Samlyn Capital, LLC
New York, NY |
May 15, 2025 Q1 2025 |
978,423
shares
|
$20.8 Million
0.39% of portfolio
|
Q1 2025
Reduced 41.14%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
919,352
shares
|
$19.5 Million
0.02% of portfolio
|
Q2 2023
New holding
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
May 09, 2025 Q1 2025 |
892,859
shares
|
$19 Million
0.01% of portfolio
|
Q1 2025
Added 10.18%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
May 05, 2025 Q1 2025 |
840,258
shares
|
$17.8 Million
0.02% of portfolio
|
Q1 2025
Reduced 0.13%
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
May 08, 2025 Q1 2025 |
788,150
shares
|
$16.7 Million
0.04% of portfolio
|
Q1 2025
Reduced 27.43%
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
758,355
shares
|
$16.1 Million
3.53% of portfolio
|
Q3 2023
Reduced 22.24%
|
|
Siren, L.L.C.
New York, NY |
May 14, 2025 Q1 2025 |
747,216
shares
|
$15.9 Million
1.02% of portfolio
|
Q1 2025
Reduced 1.48%
|